This easy-to-use service reshapes how you think about presentations, documents, and even websites by letting you pass all the design work off to AI.

Data support planned dosing regimen and protocol for FIH study to initiate in mid-2025 LONDON, May 13, 2025 (GLOBE NEWSWIRE) ...

VYKAT XR was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025, and is now commercially available to U.S. patients. VYKAT XR is indicated for the treatment of hyperphagia in ...

ATH-1105 is the Company's novel, orally available, brain-penetrant, next-generation small molecule drug candidate designed to ...

Wall Street's AI arms race is underway. Goldman Sachs is equipping thousands of staffers with custom AI tools — here's a look ...

University of Guam students and alumni presented original research at the 19th Annual International Conference on Business, ...

Norman K. Dann, Ph.D., researcher and biographer of members of the Gerrit Smith family of Peterboro, willpresent a series of ...

The videos cover roles and responsibilities, ethics and independence, people resources, and technological and intellectual resources.

Gain insights into Biodesix's Q1 2025 earnings: revenue growth, strategic salesforce reconfiguration, and updated 2025 guidance.

the Company will post an investor presentation to accompany the conference call on its website at www.ellingtoncredit.com under "For Investors—Presentations" after market close on Tuesday ...

Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat ...